Pantelis Samartsidis, Claudia R. Eickhoff, Simon B. Eickhoff, Tor D. Wager, Lisa Feldman Barrett, Shir Atzil, Timothy D. Johnson, Thomas E. Nichols Journal of the ...
Incidence, predictors and outcomes of cardiovascular events in patients with chronic lymphocytic leukemia. Summary of NMA results: PFS of zanubrutinib compared with frontline treatments for TN CLL.
Benefit of adding Cureety remote patient monitoring (RPM) to usual care during injectable anticancer treatment: The OPTIMACURE multicentric French prospective randomized study. This is an ASCO Meeting ...